Stock UniverseDerived research view · source repositories remain read-only

XOMA Royalty Corporation (XOMA)

Therapeutics / Biopharma · Healthcare / Biotechnology
Score Band
Speculative
Selection Score
25.68
Global Rank
2700
Market Cap
316.14M
Latest Close
42.09
RS Composite
39.76% · G#198

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
1.18%
3M
62.01%
6M
35.77%
1Y
68.36%
3Y
147.59%
5Y
42.82%
10Y
205.00%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 41.94K · 30-day average: 298.64K · Max drawdown over stored range: -70.80%

Research Snapshot

Relative Strength vs SPX

RS Composite39.76%
20D RS1.30%
60D RS47.15%
120D RS51.60%
Global RS Rank198 · 94.10% percentile
Watch+Speculative RS Rank109 · 94.80% percentile
Group ScopeWatch+Speculative
Primary RS Rank32 · 93.01% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank341 / 701
Primary Percentile51.50
Score Notesmarket-cap support, industry-tailwind, small-cap penalty

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

No processed TTM rows for XOMA.

TTM Valuation

No SEC TTM valuation available.

Financial Statement Metrics

MetricFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue29.38538.166.0274.75828.48752.149
Revenue Growth (YoY)59.962%29.862%-84.206%-21.055%498.718%83.062%
Gross Profit29.21537.9895.8744.61525.612
Operating Income12.41617.529-17.414-23.463-36.376
Free Cash Flow10.08322.678-12.879-18.175-13.7682.871
Free Cash Flow Per Share0.8771.86-1.128-1.584-1.1770.15965965965965967
EPS (Diluted) GAAP0.7832730.653543-1.978095-4.04-1.65
EPS Growth6100%-16.563%6100%6100%6100%
EPS Non-GAAP
Gross Margin99.421%99.552%97.461%96.995%89.908%100%
Operating Margin42.253%45.936%-288.933%-493.127%-127.693%21.8298%
Profit Margin29.923%20.406%-374.581%-973.161%-67.726%61.0079%
Free Cash Flow Margin34.313%59.429%-213.688%-381.988%-48.331%5.5054%
Shares Outstanding (Diluted)11.50312.19211.41311.47111.70117.982
Shares Change (YoY)31.268%5.99%-6.389%0.508%2.005%53.679%

SEC Quarterly Fundamentals

No processed quarterly rows for XOMA.